Improving access to affordable insulin is one of the main focuses of the ACCISS Study. Within this section you will find reports and other outputs relating to the price and availability of insulin and supplies in LMICs. We will continue to update this section as new information becomes available.
For more on price and availability, please visit our MAIn section which includes up-to-date country data.
Insulin Prices
GOVERNMENT PROCUREMENT OF INSULIN: CASE STUDIES IN 11 LMICS (2025) | Report
This report provides insights into government procurement of insulin using ACCISS collected data covering a five-year period in 11 low-and middle-income countries: Burkina Faso, Mozambique, Uganda, Comoros, Djibouti, Kyrgyzstan, Lao PDR, Lebanon, Nepal, Pakistan (Punjab Province) and Sri Lanka. This study was undertaken to better understand procurement practices and prices, and to assess the impact of Novo Nordisk’s differential pricing scheme (entitled the Access to Insulin Commitment, A2IC). This report includes price data, as well as insights into the procurement processes in the aforementioned countries.
PRICES PEOPLE PAY FOR GLARGINE INSULIN (2023) | Briefing Note
This briefing note includes the results from a snapshot survey on glargine insulin in 47 countries
PRODUCTION COSTS AND POTENTIAL PRICES FOR BIOSIMILARS OF HUMAN INSULIN AND INSULIN ANALOGUES (2018) | Article
This article, published in BMJ Global Health, provides an estimate for the cost of production for human and analogue insulins, as well as estimates what profitable prices should be w ith increased biosimilar competition.
INSULIN PRICES, AVAILABILITY AND AFFORDABILITY IN 13 LOW-INCOME AND MIDDLE-INCOME COUNTRIES (2019) | Article
In 2016, insulin price and availability surveys in three sectors were undertaken in 15 low-and middle-income countries.
INSULIN PRICE COMPONENTS: CASE STUDIES IN SIX LOW/MIDDLE-INCOME COUNTRIES (2019) | Article
This article highlights how price components on insulins can help design interventions to improve insulin affordability in LMICs.
INSULIN PRICE PROFILE (2016) |Fact Sheet | Report
This profile analyses government procurement prices for insulin, patient prices and affordability of insulin in the public and private sectors, and insulin reimbursement prices. A time-series analysis of insulin prices listed in Management Sciences for Health International Drug Price Indicator Guide is also provided.
INSULIN TAX AND TARIFFS PROFILE (2016) | Fact Sheet | Report
This profile describes import tariffs on retail insulin and bulk insulin over time, and identifies countries that continue to apply high tariff levels. It also identifies countries that apply value-added tax on insulin
Self Monitoring Glucose Devices Prices
AVAILABILITY, PRICES AND AFFORDABILITY OF SELF-MONITORING BLOOD GLUCOSE DEVICES: SURVEYS IN SIX LOW-INCOME AND MIDDLE-INCOME COUNTRIES (2025)| Article
This article assesing prices and availability of self -monitoring glucose devices (including glucose meters, test strips, lancets and CGMs) in LMICs and finds that the prices of meters, test strips and sensors remain unaffordable.
PRICE COMPONENTS OF BLOOD GLUCOSE METERS AND TEST STRIPS (2024) | Case Study
With the aim of better understanding the impact of supply chain costs on patient prices for blood glucose meters and strips, data was collected in three countries (China, Peru and Uganda). This case study provides a description of mark-ups and other costs (price components) in the private sector supply chain for blood glucose meters and test strips.